miricorilant   Click here for help

GtoPdb Ligand ID: 10059

Synonyms: C-118335 | C118335 | compound 7 [PMID: 23131342] | CORT118335
Compound class: Synthetic organic
Comment: Miricorilant (CORT118335) is a potent, orally active non-steroidal glucocorticoid receptor (GR) antagonist that is being developed by Corcept Therapeutics [2]. Selective GR antagonists are being investigated for their potential to mitigate antipsychotic-induced weight gain, a beneficial activity that was first identified using the dual GR/progesterone receptor antagonist mifepristone [1].
Hunt et al. (2010) specify CORT118335 with the InChIKey GVVUZBSCYAVFTI-IYARVYRRSA-N and as the trans isomer (or the (1r,4r) isomer) [2], which corresponds to the chemical structure submitted to the WHO for the INN miricorilant. Note that PubChem lists this compound in the form without any specified stereochemistry, with PubChem CID 66550324, and that ChEMBL record the cis (or (1s,4s)) isomer as CHEMBL2204043 (InChIKey GVVUZBSCYAVFTI-HDICACEKNA-N).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 65.72
Molecular weight 428.17
XLogP 6.11
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1[nH]c(=O)c(c([nH]1)C1CCC(CC1)c1ccccc1)Cc1cccc(c1)C(F)(F)F
Isomeric SMILES O=c1[nH]c(=O)c(c([nH]1)[C@@H]1CC[C@H](CC1)c1ccccc1)Cc1cccc(c1)C(F)(F)F
InChI InChI=1S/C24H23F3N2O2/c25-24(26,27)19-8-4-5-15(13-19)14-20-21(28-23(31)29-22(20)30)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-8,13,17-18H,9-12,14H2,(H2,28,29,30,31)/t17-,18-
InChI Key GVVUZBSCYAVFTI-IYARVYRRSA-N
Bioactivity Comments
In a reporter gene assay (measured as inhibition of dexamethasone induced luciferase expression through the glucocorticoid response element) CORT118335 has a Ki of 24 nM [2]. CORT118335 exhibited good selectivity against PR, ER and AR, with no significant affinity in receptor binding assays, and in reporter gene assays in comparison to GR only selectivity against MR (8-fold) was noteworthy. CORT118335 did not exhibit any significant liability in terms of inhibition of any of the five major human cytochrome p450 enzymes (3A4, 2D6, 1A2, 2C9, 2C19). Preclinical studies show that CORT118335 is efficacious in the rat olanzapine-induced weight gain model.
Selectivity at nuclear hormone receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Glucocorticoid receptor Primary target of this compound Hs Antagonist Antagonist 8.1 pKi - 2
pKi 8.1 (Ki 8x10-9 M) [2]
Description: Determined by measuring displacement of [3H]dexamethasone from recombinant baculovirus derived human GR.